EUVIMEDEUVIMED entdecken
Crossref

Rational design of halogen-substituted near-infrared fluorescent probes for butyrylcholinesterase: from drug screening to imaging and therapeutic evaluation in Alzheimer's disease

Lin Jiang, Jianqin Yan, Chaolong Liu, Xiaoyue Dong, Run Shi, Qingming Ma, Shiwei Sun, Yong Sun

Biosensors and Bioelectronics · 2026

DOI: 10.1016/j.bios.2026.119140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Lin Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Butyrylcholinesterase, Fluorescent Dyes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, Department of Education of Shandong Province, Taishan Industry Leading Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monitoring butyrylcholinesterase (BuChE) activity is crucial for tracking Alzheimer's disease (AD) progression and evaluating therapeutics; however, high-performance near-infrared (NIR) probes with rapid response and clear design principles remain scarce. Here, we report a series of dicyanoisophorone-based NIR fluorescent probes engineered via a "halogen effect" to systematically tune reactivity toward BuChE. Through spectroscopic screening, the CF3-substituted probe DCNC7 emerged as the optimal candidate, benefiting from the strong electron-withdrawing and hydrophobic nature of the trifluoromethyl group, which enhances binding affinity and catalytic recognition. DCNC7 exhibits over 120-fold NIR fluorescence enhancement upon the BuChE reaction, with fast kinetics (∼15 min), high sensitivity (detection limit 0.0206 U/L), and excellent selectivity. We validated DCNC7 for in situ imaging of BuChE in AD mouse cells and brain tissues, enabling both identification of natural inhibitors and longitudinal assessment of AD progression. Moreover, the screened inhibitor was evaluated for its suppressive effect on BuChE activity in brain tissue and its therapeutic efficacy in vivo. Collectively, DCNC7 offers a reliable tool for AD monitoring, drug screening, and efficacy evaluation, and the halogen effect-based design strategy provides a generalizable route to develop rapid-response, high-affinity enzyme probes for complex disease models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseButyrylcholinesteraseFluorescent DyesAnimalsHumansMiceCholinesterase InhibitorsFluorescent Chemosensor CompoundsBiosensing TechniquesBrainDrug Evaluation, Preclinical

Stichwörter der Autor:innen

Alzheimer's diseaseButyrylcholinesteraseDrug screeningFluorescence probeIn situ imaging

Substanzen

ButyrylcholinesteraseFluorescent DyesCholinesterase InhibitorsFluorescent Chemosensor Compounds

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China.
  • Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Electronic address: clliu@qdu.edu.cn.
  • Department of Natural Medicine and Pharmacognosy, School of Pharmacy, Qingdao University, Qingdao, 266071, China.
  • Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Electronic address: qma@qdu.edu.cn.
  • Department of Natural Medicine and Pharmacognosy, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Electronic address: sunsw@qdu.edu.cn.
  • Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Electronic address: sunyong@qdu.edu.cn.

Förderung

  • Shandong Province Natural Science Foundation
  • Department of Education of Shandong Province
  • Taishan Industry Leading Talents
  • Natural Science Foundation of Qingdao Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, L., Yan, J., Liu, C., Dong, X., Shi, R., Ma, Q., Sun, S., & Sun, Y. (2026). Rational design of halogen-substituted near-infrared fluorescent probes for butyrylcholinesterase: from drug screening to imaging and therapeutic evaluation in Alzheimer's disease. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119140

Vancouver

Jiang L, Yan J, Liu C, Dong X, Shi R, Ma Q, et al. Rational design of halogen-substituted near-infrared fluorescent probes for butyrylcholinesterase: from drug screening to imaging and therapeutic evaluation in Alzheimer's disease. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.119140

BibTeX
@article{Jiang2026,
  author = {Jiang, Lin and Yan, Jianqin and Liu, Chaolong and Dong, Xiaoyue and Shi, Run and Ma, Qingming and Sun, Shiwei and Sun, Yong},
  title = {Rational design of halogen-substituted near-infrared fluorescent probes for butyrylcholinesterase: from drug screening to imaging and therapeutic evaluation in Alzheimer's disease},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  doi = {10.1016/j.bios.2026.119140}
}
Kostenlos starten →